Gene · 582
BBS1: Bardet-Biedl syndrome 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BBS1: Bardet-Biedl syndrome 1. Genes, record 582. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/582
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8NFJ9 | BBSome complex member BBS1 | 593 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026515744 A | 2026-05-19 | 198 | Q8NFJ9 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38582 | Q8NFJ9 | Espacenet |
| EP 4667578 A2 | 2025-12-24 | 106 | Q8NFJ9 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5119 | Q8NFJ9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4711 | Q8NFJ9 | Espacenet |
| JP 2025131621 A | 2025-09-09 | 106 | Q8NFJ9 | Espacenet |
| JP 2025120285 A | 2025-08-15 | 9 | Q8NFJ9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4711 | Q8NFJ9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5119 | Q8NFJ9 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8235 | Q8NFJ9 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants577
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BBS1 papers | Newest fiscal year |
|---|---|---|---|
| R01GM089933 | Quality Control of the cilia proteome | 10 | 2025 |
| I01BX004249 | Neuronal Mechanisms of Obesity-Induced Hypertension | 6 | 2025 |
| P30EY025580 | Multidisciplinary Investigations in Visual Science | 5 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 4 | 2025 |
| P30DK026687 | New York Obesity Research Center | 4 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 4 | 2025 |
| R01EY022356 | Molecular Basis of Human Visual System Disorders | 4 | 2025 |
| ZIAHD000641 | Physiology, Psychology, and Genetics of Obesity | 4 | 2025 |
| ZIAHG200328 | Rare & Mosaic Disorders Molecular Research | 4 | 2025 |
| P30EY010572 | Ophthalmology Core Facility | 3 | 2025 |
1 to 10 of 577Source NIH's project files
See all 577 nih grantsPapers946
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive overview of genetic mutations in Iranian patients with Bardet-Biedl syndrome. | Mol Genet Metab Rep | 2026 | 42774553 | PubTator, text mining | PubMed |
| Whole-exome sequencing-centered genetic evaluation for early-onset obesity in Chinese children: a retrospective single-center cohort. | Transl Pediatr | 2026 | 42724349 | PubTator, text mining | PubMed |
| Mesenchymal drift in ciliopathy iPSC-derived RPE reveals a convergent pathogenic cell state. | Cell Rep | 2026 | 42667617 | PubTator, text mining | PubMed |
| Clinical, Genetic, and Endocrine Features of Bardet-Biedl Syndrome in a Pediatric and Adult Cohort. | Am J Med Genet A | 2026 | 42596080 | PubTator, text mining | PubMed |
| Smoking-Related Clinical and Molecular Abnormalities in Idiopathic Pulmonary Fibrosis-Associated Pulmonary Hypertension. | Pulm Circ | 2026 | 42454257 | PubTator, text mining | PubMed |
| Atypical Prenatal Phenotypic Spectrum: A Case Series of Four Unique Presentations With Genetic and Diagnostic Insights. | Clin Genet | 2026 | 42438042 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Reveals Promising Genes Associated with Congenital Renal Parenchymal Anomalies in Greek Children. | Children (Basel) | 2026 | 42353922 | PubTator, text mining | PubMed |
| Bardet-Biedl syndrome 1 mutations differentially impact BBSome integrity and ciliary trafficking. | Cell Commun Signal | 2026 | 42316211 | PubTator, text mining | PubMed |
| Clinical heterogeneity associated with Bardet-Biedl syndrome-related genes in presumed non-syndromic inherited retinal disease. | Front Cell Dev Biol | 2026 | 42311504 | PubTator, text mining | PubMed |
| Expanding the Utility of Exome Sequencing in Preventive and Population Genetics. | Am J Med Genet A | 2026 | 42212615 | PubTator, text mining | PubMed |
1 to 10 of 946
See all 946 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/582
GET https://conductscience.org/api/genes/v1/582/patents?page=2